| Symbol | Company | Weighting |
|---|---|---|
| ABVX | ABIVAX SA | 23.12% |
| RVMD | REVOLUTION MEDICINES INC | 4.54% |
| TVTX | TRAVERE THERAPEUTICS INC | 3.32% |
| PSNL | PERSONALIS | 3.17% |
| IMVT | IMMUNOVANT INC | 2.71% |
| CRNX | CRINETICS PHARMACEUTICALS INC | 2.71% |
| EWTX | EDGEWISE THERAPEUTICS | 2.60% |
| CYTK | CYTOKINETICS INC | 2.59% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 2.46% |
| EYPT | EYEPOINT INC | 2.14% |
| DYN | DYNE THERAPEUTICS, INC. | 1.94% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.91% |
| PCVX | VAXCYTE INC | 1.76% |
| DNLI | DENALI THERAPEUTICS INC. | 1.66% |
| GKOS | GLAUKOS CORPORATION | 1.65% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.64% |
| INSM | INSMED INC | 1.58% |
| HUM | HUMANA INC | 1.56% |
| HALO | HALOZYME THERAPEUTICS INC | 1.50% |
| ARGX | ARGENX SE ADR | 1.44% |
| UNH | UNITEDHEALTH GROUP INC | 1.39% |
| ABBV | ABBVIE INC | 1.33% |
| TARS | TARSUS PHARMACEUTICALS | 1.33% |
| GMED | GLOBUS MEDICAL INC CLASS A | 1.32% |
| ICLR | ICON PLC | 1.26% |
| AZN | ASTRAZENECA PLC | 1.24% |
| THC | TENET HEALTHCARE CORP | 1.19% |
| RGEN | REPLIGEN CORP | 1.18% |
| MCK | MCKESSON CORP | 1.16% |
| VCEL | VERICEL CORP | 1.12% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.11% |
| DHR | DANAHER CORP | 1.07% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.02% |
| HCA | HCA HOLDINGS INC | 0.99% |
| MDT | MEDTRONIC PLC | 0.97% |
| ELV | ELEVANCE HEALTH INC | 0.96% |
| REGN | REGENERON PHARMACEUTICALS | 0.94% |
| DXCM | DEXCOM INC | 0.91% |
| BDX | BECTON DICKINSON & CO | 0.90% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 0.89% |
| CDXS | CODEXIS INC | 0.88% |
| SNY | SANOFI- AVENTIS- ADR | 0.85% |
| SYK | STRYKER CORP | 0.85% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.85% |
| RMD | RESMED INC | 0.82% |
| KRRO | KORRO BIO | 0.82% |
| ALC | ALCON INC | 0.80% |
| ABT | ABBOTT LABORATORIES | 0.73% |
| TNDM | TANDEM DIABETES CARE INC | 0.71% |
| ISRG | INTUITIVE SURGICAL INC | 0.68% |
| SMMT | SUMMIT THERAPEUTICS INC. | 0.58% |
| SPRY | ARS PHARMACEUTICALS | 0.55% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.48% |
| ZTS | ZOETIS INC | 0.46% |
| ADMA | ADMA BIOLOGICS, INC. | 0.45% |
| BSX | BOSTON SCIENTIFIC | 0.42% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.33% |
| WAT | WATERS CORP | 0.29% |
| LENZ | LENZ THERAPEUTICS | 0.18% |
| AKROCV | CONTRA AKERO THERAPEUT | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) <a href="/services/prospectuses-and-reports">click here</a> or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Private Investments, LLC, Guggenheim Investments Loan Advisors, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.
